Most Searched
Telehealth appointments are available.
Monday - Friday
8 a.m - 5 p.m.
7 a.m. - 5 p.m.
Dr. Zada is a board-certified neurosurgeon and internationally recognized expert in brain, skull base and pituitary tumor surgery, as well as a variety of endoscopic and minimally invasive neurosurgical techniques. Dr. Zada has treated over 2,000 patients with brain and skull base tumors using both minimally invasive and open cranial approaches. As Director of the USC Brain Tumor Center, Dr. Zada directs a comprehensive minimally invasive cranial surgery program including endoscopic skull base/pituitary surgery, exoscopic minimally invasive parafascicular surgery (MIPS) and intraventricular neuro-endoscopy. He also co-directs the USC Radiosurgery Center and performs both Gamma Knife and TrueBeam Radiosurgery. Dr. Zada has a keen clinical and academic interest in brain and skull base tumor surgery and has published over 150 peer-reviewed articles on various topics, mostly relating to brain/pituitary tumors and skull base surgery. He co-authored and edited the textbook entitled “The Atlas of Sellar and Parasellar Lesions”, which has been downloaded over 140,000 times. He is an NIH-funded principal investigator whose research laboratory at the Zilkha Neurogenetic Institute focuses on the genomics and epigenetics of brain and pituitary tumors. Dr. Zada serves on the editorial board of The Journal of Neurosurgery.
Philosophy of care: Requiring a visit to a neurosurgeon or undergoing a neurosurgical operation can be one of the most frightening and life-changing experiences a person will ever have. Placing myself in the patient's shoes is the most important thing I can do to provide the best advice and care for any patient and family member with whom I interact. I believe in providing the safest and most effective care for my patients, founded on the principles of evidence-based medicine, research and the latest techniques available. My goal is to offer the safest and most effective surgical procedures for patients until we reach our goal of developing a cure for every subtype of malignant and benign brain tumor.
Benefits among health plans and employers vary. Please contact your health plan to verify benefits and network providers for specific products. It is important to note that not all of our providers participate in all of a health plan's products or networks.
